Effects of antiarrhythmic drugs on the hyperpolarization-activated cyclic nucleotide-gated channel current

Journal of Pharmacological Sciences

Volumn 110, Issue 2, 2009, Pages 150-159

  Tamura, Atsushi ^a   Ogura, Takehiko ^a   Uemura, Hiroko ^a   Reien, Yoshie ^a   Kishimoto, Takashi ^a   Nagai, Toshio ^a   Komuro, Issei ^a   Miyazaki, Masaru ^a   Nakaya, Haruaki ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Amiodarone; Antiarrhythmic drug; Bepridil; Hyperpolarization activated cyclic nucleotide gated (HCN) channel subtype 4; Pacemaker current

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; APRINDINE; BEPRIDIL; CIBENZOLINE; CYCLIC NUCLEOTIDE; DISOPYRAMIDE; FLECAINIDE; LIDOCAINE; MEXILETINE; PROPAFENONE; PROPRANOLOL; QUINIDINE; VERAPAMIL;

ARTICLE; CELL STRAIN HEK293; CHANNEL GATING; CONTROLLED STUDY; DRUG POTENCY; HUMAN; HUMAN CELL; HYPERPOLARIZATION; IC 50; ION TRANSPORT; MEMBRANE CURRENT; PATCH CLAMP;

EID: 67649651671     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08312FP     Document Type: Article

References (33)

1. Brown HF, DiFrancisco D, Nobel SJ. How does adrenaline accelerate the heart? Nature. 1979;280:235-236.
2. Brown HF, DiFrancesco D. Voltage clamp investigation of current underlying pacemaker activity in rabbit sino-atrial node. J Physiol. 1980;308:331-351. (Pubitemid 11252754)
3. DiFrancesco D. A new interpretation of the pace-marker current in calf Purkinje fibers. J Physiol. 1981;314:359-376. (Pubitemid 11125815)
4. Ludwig A, Zong X, Jeglitsch M, Hofmann F, Biel M. A family of hyperpolarization-activated mammalian cation channels. Nature. 1998;393:587-591. (Pubitemid 28319249)
5. Santoro B, Liu DT, Yao H, Bartsch D, Kandel ER, Siegelbaum SA, et al. Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. Cell. 1998;93:717-729. (Pubitemid 28257579)
6. Seifert R, Scholten A, Gauss R, Mincheva A, Lichter P, Kaupp UB. Molecular characterization of a slowly gating human hyperpolarization-activated channel predominant expressed in thalamus, heart, and testis. Proc Natl Acad Sci U S A. 1999;96: 9391-9396. (Pubitemid 29374765)
7. Ishii T, Takano M, Xie LH, Noma A, Ohmori H. Molecular characterization of the hyperpolarization-activated cation channel in rabbit heart sinoatrial node. J Biol Chem. 1999; 274:12835-12839. (Pubitemid 129518058)
8. Shi W, Wymore R, Yu H, Wu J, Wymore RT, Pan Z, et al. Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues. Circ Res. 1999;85:e1-e6.
9. DiFrancesco D. Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol. 1993;55:455-472. (Pubitemid 23102141)
10. Earm YE, Shimoni Y, Spindler AJ. A pace-maker-like current in the sheep atrium and its modulation by catecholamines. J Physiol. 1995;342:569-590.
11. Yu H, Chang F, Cohen IS. Pacemaker current i(f) in adult canine cardiac ventricular myocytes. J Physiol. 1995;485:469-483.
12. Cerbai E, Barbieri M, Mugelli A. Occurrence and properties of the hyperpolarization-activated current If in ventricular myocytes from normotensive and hypertensive rats during aging. Circulation. 1996;94:1674-1681. (Pubitemid 26320274)
13. f, in ventricular myocytes from human failing heart. Circulation. 1997;95:568-571.
14. Hoppe UC, Jansen E, Sudkamp M, Beuckelmann DJ. Hyperpolarization- activated inward current in ventricular myocytes from normal and failing human hearts. Circulation. 1998;97:55-65. (Pubitemid 28036155)
15. f in left human atrium: a potential contributor to atrial ectopy. Cardiovasc Res. 2004;64:250-259.
16. Zicha S, Fernadez-Velasco M, Lonardo G, L'Heurex N, Nattel S. Sinus node dysfunction and hyperpolarization-activated (HCN) channel subunit remodeling in a canine heart failure model. Cardiovasc Res. 2005;66:472-481. (Pubitemid 40725759)
17. f) in normal and failing human heart. J Mol Cell Cardiol. 2008;45:289-299.
18. Vaughan Williams EM. Classification of antiarrhythmic drugs. In: Sandoe E, Flensted-Jensen E, Olesen K, editors. Cardiac arrhythmias. Sodertalje: Astra; 1981. p. 449-472.
19. The Cardiac Arrhythmia Suppression Trial (CAST) investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;21:406-412.
20. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian Gambit: A new approach to the classification of antiarrhythmic drugs based on their actions arrhythmogenic mechanisms. Circulation. 1991;84: 1831-1851.
21. Kodama I, Ogawa S, Inoue H, Kasanuki H, Kato T, Mitamura H, et al. The Guideline Committee for Clinical Use of Antiarrhythmic Drugs in Japan (Working Group of Arrhythmias of the Japanese Society of Electrocardiology). Profiles of aprindine, cibenzoline, pilsicainide and pirmenol in the framework of the Sicilian Gambit. Jpn Circ J. 1999;63:1-12.
22. + current and experimental atrial fibrillation in guinea-pig hearts. J Pharmacol Sci. 2007;105:229-239.
23. Matsumoto Y, Aihara H, Yamaguchi-Kohno R, Reien Y, Ogura T, Yabana Y, et al. Long-term endothelin A receptor blockade inhibits electrical remodeling in cardiomyopathic hamsters. Circulation. 2002;106:613-619. (Pubitemid 34827713)
24. ATP channels in guinea pig ventricular cells. J Pharmacol Exp Ther. 2003;307:955-960.
25. f) in sino-atrial node myocytes. Pflügers Arch. 1994;427:64-70.
26. Ludwig A, Zong X, Stieber J, Hullin R, Hofmann F, Biel M. Two pacemaker channels from human heart with profoundly different activation kinetics. EMBO J. 1999;18:2323-2329. (Pubitemid 29213266)
27. Benet LZ. Pharmacokinetics and metabolism of bepridil. Am J Cardiol 1985;55:8C-13C. (Pubitemid 15143447)
28. Roden DM. Antiarrhythmic drugs. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman's The pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006. p. 899-932.
29. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659-666. (Pubitemid 28402090)
30. Chen YJ, Chen SA, Chang MS, Lin CI. Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation. Cardiovasc Res. 2000;48: 265-273. (Pubitemid 30774610)
31. Uemura H, Reien Y, Ogura T, Kishimoto T, Ishikura H, Nakaya H. Inhibitory effects of antiarrhythmic drugs on the HCN4 channel current and its electropharmacological significance. Jpn J Pharmacol. 2002;88 Suppl I:261P.
32. 2+ exchange current in guinea-pig cardiac myocytes. Br J Pharmacol. 2000;131:80-84.
33. 2+ exchange current in guinea pig cardiac ventricular myocytes. Jpn J Pharmacol. 2001;85:370-375.